Cellceutix Anti-Cancer Drug Shown to Regulate HDAC2, a Major Therapeutic Target for Treatment of a Broad Range of Cancers
January 17, 2012 | Press Releases
Cellceutix Ushers in 2012 With Plans for Clinical Trials for Anti-Cancer and Psoriasis Drugs
January 3, 2012 | Press Releases
Cellceutix Provides Updates on IND for Cancer Drug, Initiates Collaborative Agreement With Pioneer Valley Life Sciences Institute for Mitochondrial Research
December 13, 2011 | Press Releases
Dr. Paul Marks Joins Cellceutix Scientific Advisory Board; Cellceutix Files Worldwide Patents to Protect Kevetrin™
November 28, 2011 | Press Releases
Cellceutix Files Investigational New Drug Application (IND) With FDA, Clinical Trials Planned at Dana-Farber/Harvard Cancer Center
November 7, 2011 | Press Releases
Cellceutix to File Investigational New Drug Application for Novel p53 Anti-Cancer Drug
October 25, 2011 | Press Releases
Cellceutix Confident as Cancer Compound Shows Activity in All Cancers Tested
October 17, 2011 | Press Releases
Prostate Cancer Joins Growing List of Cancers That Succumb to Cellceutix Corporation’s Potent Anti-Cancer Drug
October 10, 2011 | Press Releases
Cellceutix’s Drug Discovery Is a Major Leap Forward in the Fight Against Cancer
October 3, 2011 | Press Releases